Chandan Healthcare
CHANDAN NSE
Chandan Healthcare
Healthcare ServicesNSE: CHANDAN Healthcare Service Provider
Key Fundamentals
SMEHealthcare Service ProviderHealthcare ServicesMarket Cap
₹497 Cr
Volatility
Moderate
P/E Ratio
19.74
EBITDA
₹49.65 Cr
Return on Equity
18.6%
Debt to Equity
0.32
Book Value
₹69.48
52W High
₹358
52W Low
₹185.4
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Weaknesses
3- Though the company is reporting repeated profits, it is not paying out dividend
- Debtor days have increased from 82.4 to 114 days.
- Working capital days have increased from 61.8 days to 111 days
Growth Rate
Revenue Growth
19.03% lower than
3Y
Net Income Growth
23.11% lower than
3Y
Cash Flow Change
—
ROE
-50.39% lower than
3Y
ROCE
-40.71% lower than
3Y
EBITDA Margin (Avg.)
-5.35% lower than
3Y
Quarterly Results
| Particulars | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|
| Sales | 54.64 | 62.65 | 67.9 | 67.9 | 65.01 | 75.58 | 80.85 |
| Expenses | 45.75 | 52.41 | 54.03 | 53.75 | 53.17 | 64.1 | 61.27 |
| Operating Profit | 8.89 | 10.24 | 13.87 | 14.15 | 11.84 | 11.48 | 19.58 |
| OPM % | 16.27% | 16.34% | 20.43% | 20.84% | 18.21% | 15.19% | 24.22% |
| Other Income | 0.17 | 2.42 | 0.87 | 0.84 | -1.46 | 1.85 | 1.41 |
| Interest | 1.09 | 1.3 | 1.37 | 1.4 | 1.28 | 1.78 | 4.83 |
| Depreciation | 1.35 | 2.7 | 3.75 | 2.46 | 2.4 | 3.74 | 4.47 |
| PBT | 6.62 | 8.66 | 9.62 | 11.13 | 6.7 | 7.81 | 11.69 |
| Tax % | 30.21% | 29.56% | 35.65% | 25.79% | 24.93% | 36.62% | 32.34% |
| Net Profit | 4.2 | 6.02 | 6.19 | 7.8 | 4.54 | 4.94 | 7.92 |
| EPS in Rs | 2.1 | 2.46 | 2.37 | 3.19 | 1.86 | 2 | 3.07 |
Profit & Loss
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|
| Sales | 120 | 137 | 177 | 230 | 276 | 289 |
| Expenses | 117 | 128 | 150 | 189 | 219 | 232 |
| Operating Profit | 2 | 9 | 26 | 41 | 57 | 57 |
| OPM % | 1.9% | 7% | 15% | 18% | 21% | 20% |
| Other Income | 0 | 0 | 1 | 2 | 4 | 3 |
| Interest | 2 | 2 | 3 | 5 | 14 | 9 |
| Depreciation | 2 | 2 | 3 | 7 | 15 | 13 |
| PBT | -1 | 5 | 21 | 32 | 32 | 37 |
| Tax % | 3% | 28% | 24% | 27% | 37% | — |
| Net Profit | -1 | 3 | 16 | 24 | 20 | 25 |
| EPS in Rs | -0.56 | 1.68 | 8.14 | 9.07 | 7.93 | 10.12 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Equity Capital | 20 | 20 | 20 | 24 | 24 |
| Reserves | 4 | 7 | 21 | 98 | 147 |
| Borrowings | 17 | 21 | 36 | 48 | 54 |
| Other Liabilities | 41 | 49 | 41 | 40 | 65 |
| Total Liabilities | 82 | 98 | 118 | 211 | 290 |
| Fixed Assets | 29 | 33 | 48 | 76 | 101 |
| CWIP | 0 | 0 | 0 | 4 | 12 |
| Investments | 6 | 7 | 3 | 1 | 20 |
| Other Assets | 46 | 58 | 66 | 129 | 156 |
| Total Assets | 82 | 98 | 118 | 211 | 290 |
Cash Flow
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating | 6 | 4 | 1 | -29 | 16 |
| Investing | -11 | -6 | -15 | -36 | -40 |
| Financing | 3 | 2 | 16 | 67 | 21 |
| Net Cash Flow | -1 | 0 | 2 | 2 | -3 |
| Free Cash Flow | -1 | -1 | -18 | -68 | -26 |
| CFO/OP | 275 | 60 | 23 | -50 | 45 |
Ratios
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debtor Days | 88 | 63 | 59 | 74 | 114 |
| Inventory Days | 46 | 71 | 96 | 126 | 92 |
| Days Payable | 185 | 251 | 102 | 102 | 112 |
| Cash Conversion Cycle | -51 | -117 | 53 | 98 | 95 |
| Working Capital Days | -11 | -21 | -1 | 75 | 111 |
| ROCE % | — | 16% | 37% | 29% | 23% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Chandan Healthcare insights
48 extracted metrics + investor summaries across FY22–FY26.
Documents
1
Analysts/Institutional Investor Meet/Con. Call Updates
11 Sep - Analysts’/investors’ virtual Q&A meeting held on September 11, 2026; no UPSI discussed. 11 Sep - Analysts’/investors’ virtual Q&A meeting held on September 11, 2026; no UPSI discussed.
2
Copy of Newspaper Publication
9 Sep - Newspaper advertisement published for 23rd AGM notice and e-voting instructions on 09 September 2026. 9 Sep - Newspaper advertisement published for 23rd AGM notice and e-voting instructions on 09 September 2026.
3
Analysts/Institutional Investor Meet/Con. Call Updates
7 Sep - Investor/analyst group meeting scheduled virtually on September 11, 2026 at 1:00 P.M. IST. 7 Sep - Investor/analyst group meeting scheduled virtually on September 11, 2026 at 1:00 P.M. IST.
4
Outcome of Board Meeting
7 Sep - Board recommended appointing Sanjay Srivastava as independent director and reallocated ₹50 crore warrant proceeds for new diagnostic centres. 7 Sep - Board recommended appointing Sanjay Srivastava as independent director and reallocated ₹50 crore warrant proceeds for new diagnostic centres.
5
Shareholders meeting
7 Sep - Submitted FY2025-26 annual report and AGM notice; 23rd AGM on 30 September 2026 at 4:00 PM via VC. 7 Sep - Submitted FY2025-26 annual report and AGM notice; 23rd AGM on 30 September 2026 at 4:00 PM via VC.
Frequently Asked Questions about Chandan Healthcare
What does Chandan Healthcare Ltd do?
Incorporated in September 2003, Chandan Healthcare Limited runs diagnostic centers in North India with pathology and radiology testing services.[1]
Where is Chandan Healthcare Ltd (CHANDAN) listed?
Chandan Healthcare Ltd trades as CHANDAN on the NSE.
Which sector does Chandan Healthcare Ltd belong to?
Chandan Healthcare Ltd is classified under the Healthcare Services sector, in the Healthcare Service Provider industry.
What is the market capitalisation of Chandan Healthcare Ltd?
Chandan Healthcare Ltd has a market capitalisation of ₹496.62 Cr, which places it in the Small Cap band.
What is the PE ratio of Chandan Healthcare Ltd?
Chandan Healthcare Ltd trades at a PE ratio of 19.74, against a book value of ₹69.48 per share.
What is the 52-week high and low of Chandan Healthcare Ltd?
Over the last 52 weeks Chandan Healthcare Ltd has traded between ₹185.4 and ₹358.
What is the Return on Equity (ROE) of Chandan Healthcare Ltd?
Chandan Healthcare Ltd reported a return on equity of 18.60%. Its debt-to-equity ratio is 0.32.
Company Information
Incorporated in September 2003, Chandan Healthcare Limited runs diagnostic centers in North India with pathology and radiology testing services.[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/CHANDAN.md for Chandan Healthcare Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.